{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:26:49Z","timestamp":1790908009483,"version":"4.1.0"},"reference-count":29,"publisher":"American Association for Cancer Research (AACR)","issue":"1","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Purpose: Replication-selective tumor-specific viruses present a novel approach for treating neoplastic disease. These vectors are designed to induce virus-mediated lysis of tumor cells after selective viral propagation within the tumor. Telomerase activation is considered to be a critical step in carcinogenesis, and its activity is closely correlated with human telomerase reverse transcriptase (hTERT) expression. We investigated the antitumor effect of the hTERT-specific replication-competent adenovirus on human cancer cells.<\/jats:p>\n               <jats:p>Experimental Design: We constructed an adenovirus 5 vector [tumor- or telomerase-specific replication-competent adenovirus (TRAD)], in which the hTERT promoter element drives expression of E1A and E1B genes linked with an internal ribosome entry site, and we examined the selective replication and antitumor effect in human cancer cells in vitro and in vivo.<\/jats:p>\n               <jats:p>Results: TRAD induced selective E1A and E1B expression in human cancer cells, but not in normal cells such as human fibroblasts. TRAD replicated efficiently and induced marked cell killing in a panel of human cancer cell lines, whereas replication as well as cytotoxicity was highly attenuated in normal human fibroblasts lacking telomerase activity. In nu\/nu mice carrying s.c. human lung tumor xenografts, intratumoral injection of TRAD resulted in a significant inhibition of tumor growth. No evidence of TRAD was identified in tissues outside of the tumors, despite the presence of TRAD in the circulation. Moreover, TRAD replication in the distant, noninjected tumors was demonstrated.<\/jats:p>\n               <jats:p>Conclusions: Our results suggest that the hTERT promoter confers competence for selective replication of TRAD in human cancer cells, an outcome that has important implications for the treatment of human cancers.<\/jats:p>","DOI":"10.1158\/1078-0432.ccr-1075-3","type":"journal-article","created":{"date-parts":[[2005,9,21]],"date-time":"2005-09-21T23:52:12Z","timestamp":1127346732000},"page":"285-292","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":227,"title":["Telomerase-Specific Replication-Selective Virotherapy for Human Cancer"],"prefix":"10.1158","volume":"10","author":[{"given":"Takeshi","family":"Kawashima","sequence":"first","affiliation":[{"name":"1Division of Surgical Oncology, Department of Surgery, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan;2"},{"name":"Center for Gene and Cell Therapy, Okayama University Hospital, Okayama, Japan; and3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Kagawa","sequence":"additional","affiliation":[{"name":"1Division of Surgical Oncology, Department of Surgery, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan;2"},{"name":"Center for Gene and Cell Therapy, Okayama University Hospital, Okayama, Japan; and3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"1Division of Surgical Oncology, Department of Surgery, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan;2"},{"name":"Center for Gene and Cell Therapy, Okayama University Hospital, Okayama, Japan; and3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Shirakiya","sequence":"additional","affiliation":[{"name":"1Division of Surgical Oncology, Department of Surgery, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan;2"},{"name":"Center for Gene and Cell Therapy, Okayama University Hospital, Okayama, Japan; and3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Umeoka","sequence":"additional","affiliation":[{"name":"1Division of Surgical Oncology, Department of Surgery, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan;2"},{"name":"Center for Gene and Cell Therapy, Okayama University Hospital, Okayama, Japan; and3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuminori","family":"Teraishi","sequence":"additional","affiliation":[{"name":"1Division of Surgical Oncology, Department of Surgery, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan;2"},{"name":"Center for Gene and Cell Therapy, Okayama University Hospital, Okayama, Japan; and3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Taki","sequence":"additional","affiliation":[{"name":"1Division of Surgical Oncology, Department of Surgery, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan;2"},{"name":"Center for Gene and Cell Therapy, Okayama University Hospital, Okayama, Japan; and3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Kyo","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Kanazawa University School of Medicine, Kanazawa, Japan"},{"name":"Center for Gene and Cell Therapy, Okayama University Hospital, Okayama, Japan; and3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Tanaka","sequence":"additional","affiliation":[{"name":"1Division of Surgical Oncology, Department of Surgery, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan;2"},{"name":"Center for Gene and Cell Therapy, Okayama University Hospital, Okayama, Japan; and3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyoshi","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"1Division of Surgical Oncology, Department of Surgery, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan;2"},{"name":"Center for Gene and Cell Therapy, Okayama University Hospital, Okayama, Japan; and3"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2004,1,20]]},"reference":[{"key":"2023011320421998100_B1","doi-asserted-by":"crossref","unstructured":"Swisher S. G., Roth J. A., Nemunaitis J., Lawrence D. D., Kemp B. L., Carrasco C. H., Connors D. G., El-Naggar A. K., Fossella F., Glisson B. S., Hong W. K., Khuri F. R., Kurie J. M., Lee J. J., Lee J. S., Mack M., Merritt J. A., Nguyen D. M., Nesbitt J. C., Perez-Soler R., Pisters M. W., Putnam J. B., Richli W. R., Savin M., Schrump D. S., Shin D. M., Shulkin A., Walsh G. L., Wait J., Weil D., Kimberly A., Waugh A. Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer. J. Natl. Cancer Inst. (Bethesda), 91:\u2008763-771, \u20081999.","DOI":"10.1093\/jnci\/91.9.763"},{"key":"2023011320421998100_B2","doi-asserted-by":"crossref","unstructured":"Kirn D., Martuza R. L., Zwiebel J. Replication-selective virotherapy for cancer: biological principles, risk management and future directions. Nat. Med., 7:\u2008781-787, \u20082001.","DOI":"10.1038\/89901"},{"key":"2023011320421998100_B3","doi-asserted-by":"crossref","unstructured":"Blackburn E. H. Structure and function of telomeres. Nature (Lond.), 350:\u2008569-573, \u20081991.","DOI":"10.1038\/350569a0"},{"key":"2023011320421998100_B4","doi-asserted-by":"crossref","unstructured":"Kim N. W., Piatyszek M. A., Prowse K. R., Harley C. B., West M. D., Ho P. L., Coviello G. M., Wright W. E., Weinrich S. L., Shay J. W. Specific association of human telomerase activity with immortal cells and cancer. Science (Wash. DC), 266:\u20082011-2015, \u20081994.","DOI":"10.1126\/science.7605428"},{"key":"2023011320421998100_B5","doi-asserted-by":"crossref","unstructured":"Shay J. W., Wright W. E. Telomerase activity in human cancer. Curr. Opin. Oncol., 8:\u200866-71, \u20081996.","DOI":"10.1097\/00001622-199601000-00012"},{"key":"2023011320421998100_B6","doi-asserted-by":"crossref","unstructured":"Feng J., Funk W. D., Wang S. S., Weinrich S. L., Avilion A. A., Chiu C. P., Adams R. R., Chang E., Allsopp R. C., Yu J., Le S., West M. D., Harley C. B., Andrews W. H., Greider C. W., Villeponteau B. The RNA component of human telomerase. Science (Wash. DC), 269:\u20081236-1241, \u20081995.","DOI":"10.1126\/science.7544491"},{"key":"2023011320421998100_B7","doi-asserted-by":"crossref","unstructured":"Harrington L., McPhail T., Mar V., Zhou W., Oulton R., Bass M. B., Arruda I., Robinson M. O. A mammalian telomerase-associated protein. Science (Wash. DC), 275:\u2008973-977, \u20081997.","DOI":"10.1126\/science.275.5302.973"},{"key":"2023011320421998100_B8","doi-asserted-by":"crossref","unstructured":"Meyerson M., Counter C. M., Eaton E. N., Ellisen L. W., Steiner P., Caddle S. D., Ziaugra L., Beijersbergen R. L., Davidoff M. J., Liu Q., Bacchetti S., Haber D. A., Weinberg R. A. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell, 90:\u2008785-795, \u20081997.","DOI":"10.1016\/S0092-8674(00)80538-3"},{"key":"2023011320421998100_B9","doi-asserted-by":"crossref","unstructured":"Nakamura T. M., Morin G. B., Chapman K. B., Weinrich S. L., Andrews W. H., Lingner J., Harley C. B., Cech T. R. Telomerase catalytic subunit homologs from fission yeast and human. Science (Wash. DC), 277:\u2008955-959, \u20081997.","DOI":"10.1126\/science.277.5328.955"},{"key":"2023011320421998100_B10","doi-asserted-by":"crossref","unstructured":"Nakayama J., Tahara H., Tahara E., Saito M., Ito K., Nakamura H., Nakanishi T., Tahara E., Ide T., Ishikawa F. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat. Genet., 18:\u200865-68, \u20081998.","DOI":"10.1038\/ng0198-65"},{"key":"2023011320421998100_B11","doi-asserted-by":"crossref","unstructured":"Beattie T. L., Zhou W., Robinson M. O., Harrington L. Reconstitution of human telomerase activity in vitro.. Curr. Biol., 8:\u2008177-180, \u20081998.","DOI":"10.1016\/S0960-9822(98)70067-3"},{"key":"2023011320421998100_B12","unstructured":"Takakura M., Kyo S., Kanaya T., Hirano H., Takeda J., Yutsudo M., Inoue M. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res., 59:\u2008551-557, \u20081999."},{"key":"2023011320421998100_B13","doi-asserted-by":"crossref","unstructured":"Abdul-Ghani R., Ohana P., Matouk I., Ayesh S., Ayesh B., Laster M., Bibi O., Giladi H., Molnar-Kimber K., Sughayer M. A., de Groot N., Hochberg A. Use of transcriptional regulatory sequences of telomerase (hTER and hTERT) for selective killing of cancer cells. Mol. Ther., 2:\u2008539-544, \u20082000.","DOI":"10.1006\/mthe.2000.0196"},{"key":"2023011320421998100_B14","doi-asserted-by":"crossref","unstructured":"Komata T., Koga S., Hirohata S., Takakura M., Germano I. M., Inoue M., Kyo S., Kondo S., Kondo Y. A novel treatment of human malignant gliomas in vitro and in vivo: FADD gene transfer under the control of the human telomerase reverse transcriptase gene promoter. Int. J. Oncol., 19:\u20081015-1020, \u20082001.","DOI":"10.3892\/ijo.19.5.1015"},{"key":"2023011320421998100_B15","unstructured":"Komata T., Kondo Y., Kanzawa T., Hirohata S., Koga S., Sumiyoshi H., Srinivasula S. M., Barna B. P., Germano I. M., Takakura M., Inoue M., Alnemri E. S., Shay J. W., Kyo S., Kondo S. Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter. Cancer Res., 61:\u20085796-5802, \u20082001."},{"key":"2023011320421998100_B16","doi-asserted-by":"crossref","unstructured":"Komata T., Kondo Y., Kanzawa T., Ito H., Hirohata S., Koga S., Sumiyoshi H., Takakura M., Inoue M., Barna B. P., Germano I. M., Kyo S., Kondo S. Caspase-8 gene therapy using the human telomerase reverse transcriptase promoter for malignant glioma cells. Hum. Gene Ther., 13:\u20081015-1025, \u20082002.","DOI":"10.1089\/104303402753812421"},{"key":"2023011320421998100_B17","unstructured":"Gu J., Kagawa S., Takakura M., Kyo S., Inoue M., Roth J. A., Fang B. Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers. Cancer Res., 60:\u20085359-5364, \u20082000."},{"key":"2023011320421998100_B18","doi-asserted-by":"crossref","unstructured":"Bischoff J. R., Kirn D. H., Williams A., Heise C., Horn S., Muna M., Ng L., Nye J. A., Sampson-Johannes A., Fattaey A., McCormick F. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science (Wash. DC), 274:\u2008373-376, \u20081996.","DOI":"10.1126\/science.274.5286.373"},{"key":"2023011320421998100_B19","doi-asserted-by":"crossref","unstructured":"Rothmann T., Hengstermann A., Whitaker N. J., Scheffner M., zur Hausen H. Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells. J. Virol., 72:\u20089470-9478, \u20081998.","DOI":"10.1128\/JVI.72.12.9470-9478.1998"},{"key":"2023011320421998100_B20","unstructured":"Geoerger B., Grill J., Opolon P., Morizet J., Aubert G., Terrier-Lacombe M. J., Bressac De-Paillerets B., Barrois M., Feunteun J., Kirn D. H., Vassal G. Oncolytic activity of the E1B-55 kDa-deleted adenovirus ONYX-015 is independent of cellular p53 status in human malignant glioma xenografts. Cancer Res., 62:\u2008764-772, \u20082002."},{"key":"2023011320421998100_B21","unstructured":"Rodriguez R., Schuur E. R., Lim H. Y., Henderson G. A., Simons J. W., Henderson D. R. Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells. Cancer Res., 57:\u20082559-2563, \u20081997."},{"key":"2023011320421998100_B22","doi-asserted-by":"crossref","unstructured":"Kurihara T., Brough D. E., Kovesdi I., Kufe D. W. Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen. J. Clin. Investig., 106:\u2008763-771, \u20082000.","DOI":"10.1172\/JCI9180"},{"key":"2023011320421998100_B23","unstructured":"Matsubara S., Wada Y., Gardner T. A., Egawa M., Park M. S., Hsieh C. L., Zhau H. E., Kao C., Kamidono S., Gillenwater J. Y., Chung L. W. A conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasis. Cancer Res., 61:\u20086012-6019, \u20082001."},{"key":"2023011320421998100_B24","unstructured":"Peng X. Y., Won J. H., Rutherford T., Fujii T., Zelterman D., Pizzorno G., Sapi E., Leavitt J., Kacinski B., Crystal R., Schwartz P., Deisseroth A. The use of the l-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines. Cancer Res., 61:\u20084405-4413, \u20082001."},{"key":"2023011320421998100_B25","unstructured":"Adachi Y., Reynolds P. N., Yamamoto M., Wang M., Takayama K., Matsubara S., Muramatsu T., Curiel D. T. A midkine promoter-based conditionally replicative adenovirus for treatment of pediatric solid tumors and bone marrow tumor purging. Cancer Res., 61:\u20087882-7888, \u20082001."},{"key":"2023011320421998100_B26","unstructured":"Tsukuda K., Wiewrodt R., Molnar-Kimber K., Jovanovic V. P., Amin K. M. An E2F-responsive replication-selective adenovirus targeted to the defective cell cycle in cancer cells: potent antitumoral efficacy but no toxicity to normal cell. Cancer Res., 62:\u20083438-3447, \u20082002."},{"key":"2023011320421998100_B27","doi-asserted-by":"crossref","unstructured":"Wirth T., Zender L., Schulte B., Mundt B., Plentz R., Rudolph K. L., Manns M., Kubicka S., Kuhnel F. A. telomerase-dependent conditionally replicating adenovirus for selective treatment of cancer. Cancer Res., 63:\u20083181-3188, \u20082003.","DOI":"10.1016\/S0168-8278(03)80118-6"},{"key":"2023011320421998100_B28","unstructured":"Deng J., Kloosterbooer F., Xia W., Hung M-C. The NH2-terminal and conserved region 2 domains of adenovirus E1A mediate two distinct mechanisms of tumor suppression. Cancer Res., 62:\u2008346-350, \u20082002."},{"key":"2023011320421998100_B29","unstructured":"Li Y., Yu D. C., Chen Y., Amin P., Zhang H., Nguyen N., Henderson D. R. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin. Cancer Res., 61:\u20086428-6436, \u20082001."}],"container-title":["Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article-pdf\/10\/1\/285\/1951087\/zdf00104000285.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article-pdf\/10\/1\/285\/1951087\/zdf00104000285.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T21:21:26Z","timestamp":1673644886000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article\/10\/1\/285\/165814\/Telomerase-Specific-Replication-Selective"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1,1]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2004,1,20]]},"published-print":{"date-parts":[[2004,1,1]]}},"URL":"https:\/\/doi.org\/10.1158\/1078-0432.ccr-1075-3","relation":{},"ISSN":["1078-0432","1557-3265"],"issn-type":[{"value":"1078-0432","type":"print"},{"value":"1557-3265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1,1]]}}}